scorecardresearch
Business Today
Subscribe
Immersives UPSTART ICC World Cup Corporate Petrol-Diesel Weather BT Bazaar
BT Golf BT 500 Zero Mile Samvad - IIM Nagpur BT-TR GCC Listing
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • zero mile samvad iim nagpur
News
Markets
Stocks
Concord Drugs Ltd

Feedback
Concord Drugs Ltd

Concord Drugs Ltd Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 11,614
Dec 15, 2023 10:56 IST-
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹44.01
₹0.99 (2.30%)
    Powered By :
₹43.1 Low
Today’s Performance
₹45 High
₹24.8 Low
52 Week’s Performance
₹45 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day 2.30%
  • 1 Week 19.14%
  • 1 Month 30.36%
  • 3 Months 22.98%
  • 6 Months 57.41%
  • 1 Year 34.02%
  • 3 Years 24.67%
  • 5 Years 12.62%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 0.51
  • 52-Week Low (₹) 24.80
  • 52-Week High (₹) 45.00
  • Price-to-Book (X)* 1.21
  • Dividend Yield (%) 0.00
  • Price-to-Earnings (P/E) (X)* 0.51
  • Earnings Per Share (₹) 1.79
  • Sector Price Earning (X)* 32.73
  • Market Cap (₹ Cr.)* 40.08
  • * Vaues as of last close price

COMPETITORS

BT TV

thumb 1:59 Sudeep Shah From SBI Securities Identifies Two Stocks Poised For Strong Upside Movement!
thumb 3:29 Shri Krishna Janmabhoomi Case: High Court Approves Survey Of Shahi Idgah Complex
thumb 2:07 Listen To SMIFS' Sharad Avasthi's Call On DOMS & India Shelter Finance IPOs Ending On Friday
thumb 2:09 Electrifying Delhi's Commute: Delhi's Got More Electric Buses! Hop On Board For A Greener Commute!
thumb 3:59 Derek O'Brien Suspended After Face-off With RS Chairman! MP Charged With "Ignoble Misconduct"
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

No Data For Block Deal.

*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Mar 02, 2021 PURCHASE
CONCORD ,NAGI REDDY SEELAM
  • Qty 44429
  • Average Price ₹25.00
Mar 02, 2021 Sell
CONCORD ,MOHIT BUNG
  • Qty 47381
  • Average Price ₹25.01
Mar 03, 2021 PURCHASE
CONCORD ,NAGI REDDY SEELAM
  • Qty 39716
  • Average Price ₹24.99
Aug 31, 2021 Sell
CONCORD ,MANISH RATILAL GALA
  • Qty 40000
  • Average Price ₹26.11
Sep 20, 2021 Sell
CONCORD ,SHAHABUDDIN QURRAM MOHAMMED
  • Qty 45930
  • Average Price ₹27.21
Feb 02, 2021 PURCHASE
CONCORD ,AAKANKSHA
  • Qty 50000
  • Average Price ₹25.25
Feb 02, 2021 Sell
CONCORD ,ADAMANT CONSTRUCTIONS
  • Qty 79910
  • Average Price ₹25.15
Feb 03, 2021 PURCHASE
CONCORD ,GOPIDI
  • Qty 40000
  • Average Price ₹25.00
Feb 03, 2021 Sell
CONCORD ,WELKIN INFRA DEVELOPERS
  • Qty 80000
  • Average Price ₹25.00
Mar 01, 2021 PURCHASE
CONCORD ,NAGI REDDY SEELAM
  • Qty 40524
  • Average Price ₹25.00
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Concord Drugs Ltd share price previously?
Concord Drugs Ltd share price was up by 2.30% from the previous closing price of ₹43.02.
Who are peers of Concord Drugs Ltd?
The peers of Concord Drugs Ltd are Torrent Pharmaceuticals Ltd, Ipca Laboratories Ltd, Gland Pharma Ltd, Cipla Ltd, Syngene International Ltd, Aurobindo Pharma Ltd, Alkem Laboratories Ltd, Biocon Ltd, Glaxosmithkline Pharmaceuticals Ltd, Zydus Lifesciences Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Divis Laboratories Ltd, Sun Pharmaceuticals Industries Ltd.
Who is/are the promoter/promoters of Concord Drugs Ltd?
The promotor/promotors of Concord Drugs Ltd are S Nagi Reddy, K Ramchandra Reddy, Koni Reddy, S. Nagavenkata Hareesh, S. Manoj Kumar Reddy, Summela Kasu.
What has been 52-week high of Concord Drugs Ltd stocks?
The highest price of Concord Drugs Ltd stock is ₹45.00 in the last 52-week.
What is the share price of Concord Drugs Ltd () today on BSE?
As on Dec 15, 2023, Concord Drugs Ltd ()’s share price on BSE is Rs 44.01
What is the market cap of Concord Drugs Ltd (?)
The current market capitalisation of Concord Drugs Ltd () is 40.08 crores
What is Concord Drugs Ltd Share symbol?
The symbol of Concord Drugs Ltd is .
What is the PE ratio of Concord Drugs Ltd ()?
The current PE ratio of Concord Drugs Ltd () is 0.51.
What is the PB ratio of Concord Drugs Ltd ()?
The current PB ratio of Concord Drugs Ltd () is 1.21.
Today’s High & Low share prices of Concord Drugs Ltd () on BSE?
Today, the share price of Concord Drugs Ltd () on BSE touched a high of Rs 45 and a low of Rs 43.1
What price did Concord Drugs Ltd () shares open on the BSE today?
On BSE, the share price of Concord Drugs Ltd () opened at Rs 44.7
What is the 52-week high of Concord Drugs Ltd ()?
The 52-week high price of Concord Drugs Ltd () is Rs 45
What is the 52-week low of Concord Drugs Ltd () ?
The 52-week low price of Concord Drugs Ltd () is Rs 24.8

ABOUT CONCORD DRUGS

Concord Drugs Ltd, incorporated in the year 1995, has its registered office in Survey No 249 Brahmanapally V, Hayathnagar M, Ranga Reddy, Telangana, 501511, 91-40-24036379. The main industry in which Concord Drugs Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Concord Drugs Ltd is/are Pundrikakshyam & Associates. In the main management, S Nagi Reddy is chairman and is the company secretary for Concord Drugs Ltd.

  • SNR S Nagi Reddy Chairman & Managing Director
  • KRR K Ramchandra Reddy Independent Director
  • KR Koni Reddy Whole Time Director & CFO
  • SNH S. Nagavenkata Hareesh Independent Director
  • SMKR S. Manoj Kumar Reddy Whole-time Director
  • SK Summela Kasu Independent Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement